IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 34 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $5,000 | 0.0% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $5,000 | -16.7% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $6,000 | 0.0% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $6,000 | -33.3% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $9,000 | -25.0% | 13,000 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $12,000 | -20.0% | 13,000 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $15,000 | -6.2% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $16,000 | -33.3% | 13,000 | -50.0% | 0.00% | +200.0% |
| Q4 2013 | $24,000 | -7.7% | 26,000 | +160.0% | 0.00% | -83.3% |
| Q3 2013 | $26,000 | -33.3% | 10,000 | -50.0% | 0.01% | -33.3% |
| Q2 2013 | $39,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,471,500 | $1,199,000 | 0.53% |
| SABBY MANAGEMENT, LLC | 5,889,021 | $2,856,000 | 0.12% |
| Callan Capital, LLC | 323,912 | $157,000 | 0.03% |
| CHELSEA COUNSEL CO | 28,000 | $14,000 | 0.00% |
| Ifrah Financial Services, Inc. | 18,500 | $9,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 366,060 | $178,000 | 0.00% |
| B. Riley Wealth Management, Inc. | 8,000 | $3,000 | 0.00% |
| Gerstein Fisher | 13,000 | $6,000 | 0.00% |
| First Allied Advisory Services, Inc. | 45,000 | $22,000 | 0.00% |
| NORTHERN TRUST CORP | 99,019 | $48,000 | 0.00% |